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Abstract: The present study investigated the association of carbohydrate intake and isocaloric
substitution with different types of fat with visceral adipose tissue (VAT), subcutaneous adipose
tissue (SAT) and hepatic fat content as determined by magnetic resonance imaging (MRI). Data from
283 participants (mean age 56.1 ± 9.0 years) from the MRI sub study of the KORA FF4 study were
included. VAT, SAT and total body fat were quantified by a volume-interpolated VIBE-T1w-Dixon
MR sequence. Hepatic fat content was determined as the proton density fat-fraction (PDFF) derived
from multiecho-T1w MR sequence. Dietary intake was estimated using information provided by two
different instruments, that is, repeated 24-h food lists and a food frequency questionnaire. Replacing
total carbohydrates with an isoenergetic amount of total fat was significantly positively associated
with VAT and hepatic fat, while there was no significant association with SAT. The multivariable
adjusted β-coefficient for replacing 5% of total energy (5E%) carbohydrates with total fat was 0.42 L
(95% CI: 0.04, 0.79) for VAT. A substitution in total fat intake by 5E% was associated with a significant
increase in liver fat content by 23% (p-value 0.004). If reproduced in prospective studies, such findings
would strongly argue for limiting dietary fat intake.
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1. Introduction
Obesity, a worldwide epidemic due to the availability of many unhealthy food options and limited
physical exercise [1], is a known risk factor for many metabolic disorders like coronary heart disease,
malignancies, osteoarthritis and respiratory disorders [2].
Weight gain and a subsequent increase of body fat content causes an enlargement of adipocytes
and goes along with an increase not only of subcutaneous fat but also of fat depots in other parts of the
body. This ectopic fat is mainly stored intra-abdominally but also in muscle tissue, the liver and in the
beta cells. Although both subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) are
metabolically active, the excess accumulation of VAT appears to play a more significant pathogenic
role. Fat depots in liver and muscle tissue also can cause adverse cardiometabolic effects [3,4].
Between the late seventies and 2000, there was a change in the macronutrient composition of the
diet; due to the advice on reducing fat intake, especially saturated fat, to decrease the incidence of
dyslipoproteinemia and coronary heart disease (CHD), the relative proportion of energy from total
fat decreased and that from carbohydrates increased over time [5]. In parallel, the contribution of
carbohydrates from whole grain consumption to total carbohydrate intake decreased while the intake
of refined starchy products and sugar-containing food increased [6,7].
The association between macronutrient intake and its influence on body fat depots was mainly
investigated in animal studies [8] and very few human studies [9] so far. Here, we hypothesize that the
proportion of carbohydrate and fat intake in the diet may play an important role in the accumulation
of adipose tissue at different sites and liver fat accumulation in middle-aged adult men and women.
Thus, the present study investigated the association of carbohydrate intake and isocaloric substitution
with different types of fat with VAT, SAT and hepatic fat content as determined by MRI.
2. Materials and Methods
2.1. Study Population
The analysis was based on the KORA-FF4 study, the second follow-up study of the KORA Survey
S4, conducted in 1999–2001. The study design was described in detail elsewhere [10]. Shortly, of those
participating in the KORA-Survey S4, a total of 2279 men and women participated in the 14-year
follow-up FF4 (2013/2014) [10]. A total of 400 individuals who participated in the FF4 study and met the
inclusion criteria were included in a sub-study, the so-called KORA-MRI study. All subjects included
in this sample, which was enriched with individuals with type 2 diabetes and prediabetes, received a
whole body MRI. The study design, the sampling procedure, the data collection and the inclusion and
exclusion criteria were described in detail elsewhere [11]. For the present analysis, a total of 117 study
participants had to be excluded because of missing values in the MRI parameters of interest due to
insufficient image quality, imaging artifacts or technical errors (n = 29), missing nutrition data (n = 82)
or missing values in any covariable (n = 6) (compare Figure 1).
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Figure 1. After excluding subjects with missing values, a total of 283 participants who underwent 
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repeated 24-h food lists [12]. Combining this information, the usual dietary intake was estimated in 
a two-step approach. The consumption probability and the consumption amount on consumption 
days were estimated separately with models both including the same covariates to link the two parts. 
Then, the usual dietary intake of all food items was calculated for each participant by multiplying the 
consumption probability of a certain food item by the usual consumption amount on a consumption 
day [13,14]. Nutrient contents of food items were derived from the German Nutrient Database 
Bundeslebensmittelschlüssel, version 3.02. For the present analysis, we focused on energy-providing 
nutrients (fat, carbohydrates, protein, alcohol) and the fat subgroups of saturated fatty acids (SFA), 
monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA). Alcohol intake was 
also assessed and categorized into three categories: no or very low alcohol consumption (<2 g/day for 
women, <5 g/day for men); moderate alcohol intake (≥2 g/day to <10 g/day for women; ≥5 g/day to 
<20 g/day for men) and high alcohol intake (≥10 g/day for women, ≥20 g/day for men). 
2.3. Magnetic Resonance Imaging (MRI) 
MRI scans were performed with a 3 Tesla Magnetom Skyra (Siemens Healthineers, Erlangen, 
Germany) equipped with a whole-body coiling system. Details on the whole-body protocol are 
described in detail elsewhere [11]. A multiecho Dixon-sequence was used to quantify the lipid content 
at the level of the portal vein [15]. The hepatic adipose content is given in %. 
SAT and VAT was measured by a 3D in/opposed-phase VIBE Dixon sequence and segmented 
by an automated procedure based on fuzzy-clustering. SAT in liter (L) was quantified from the 
diaphragm to the femoral head and VAT in L was measured from the cardiac apex to the femoral 
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Figure 1. After excluding subject wi h missing lues, a t tal of 283 participants who underwent
whole-body magnetic resonance imaging (MRI) could be included in the analysis.
2.2. Dietary Assessment
Dietary intake was assessed using a self-administered food frequency questionnaire (FFQ) and
repeated 24-h food lists [12]. Combining this information, the usual dietary intake was estimated in
a two-step approac . The consumption probability and the consum tion amou t on consumption
days were estimated separately with models both including the same covariates to link the two parts.
Then, the usual dietary intake of all food items was calculated for each participant by multiplying the
consumption probability of a certain food item by the usual consumption amount on a consumption
day [13,14]. Nutrient co tents of fo d items were derived from the German Nutrient Database
Bundeslebensmittelschlüssel, version 3.02. For the present analysis, we focused on energy-providing
nutrients (fat, carbohydrates, protein, alcohol) and the fat subgroups of saturated fatty acids (SFA),
monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA). Alcohol intake was
also assessed and categorized into three categories: no or very low alcohol consumption (<2 g/day for
women, <5 g/day for men); moderate alcohol intake (≥2 g/day to <10 g/day for women; ≥5 g/day to
<20 g/day for men) and high alcohol intake (≥10 g/day for women, ≥20 g/day for men).
2.3. Magnetic Resonance Imaging (MRI)
MRI scans were performed with a 3 Tesla Magnetom Skyra (Siemens Healthineers, Erlangen,
Germany) equipped with a whole-body coiling system. Details on the whole-body protocol are
described in detail elsewhere [11]. A multiecho Dixon-sequence was used to quantify the lipid content
at the level of the portal vein [15]. The hepatic adipose content is given in %.
SAT and VAT was measured by a 3D in/opposed-phase VIBE Dixon sequence and segmented by
an automated procedure based on fuzzy-clustering. SAT in liter (L) was quantified from the diaphragm
to the femoral head and VAT in L was measured from the cardiac apex to the femoral head [4].
2.4. Assessment of Covariables
After an overnight fast of at least 8 h, all non-diabetic participants underwent a standard 75-g oral
glucose tolerance test (OGTT). Newly diagnosed diabetes (NDD; ≥126 mg/dL fasting plasma glucose
or ≥200 mg/dL 2-h post glucose load), i-IFG (fasting plasma glucose ≥110 mg/dL but <126 mg/dL and
2-h post glucose load <140 mg/dL), i-IGT (fasting plasma glucose <110 mg/dL and 2-h post glucose
load ≥140 mg/dL but <200 mg/dL), IFG/IGT and normal glucose tolerance (NGT; fasting plasma
glucose <110 mg/dL and 2-h post glucose load <140 mg/dL) were defined according to the 1999 WHO
diagnostic criteria as described elsewhere [16].
Information on sociodemographic characteristics, lifestyle and risk factors and medications was
gathered during a standardized face-to-face interview. In addition, study participants underwent
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a medical examination as described in more detail elsewhere [17]. BMI was calculated as weight
in kilograms divided by the square of height in meters. Systolic and diastolic blood pressure
were measured three times using the right arm of seated participants, after at least 5 min at rest.
Subsequently, the mean of the second and third measurement was calculated. Hypertension was
defined as blood pressure values ≥140/90 mmHg and/or the use of antihypertensive medication, given
that the individuals were aware of being hypertensive. Physical activity assessment was based on
information regarding leisure-time physical training during summer and winter and a 4 categories
variable was built [18].
2.5. Clinical Chemical Measurements
A fasting venous blood sample was obtained from all study participants while sitting. All
parameters were measured immediately. Blood glucose was analyzed using an enzymatic reference
method with hexokinase. HbA1c was determined using a cation-exchange high performance liquid
chromatographic, photometric VARIANT II TURBO HbA1c Kit (Bio-Rad Laboratories Inc., Hercules,
CA, USA).
Total serum cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides analyses were carried
out using an enzymatic, colorimetric method. Liver enzymes were measured using an enzymatic,
colorimetric method. After about half of the study period, the KORA FF4 measurement instrument and
assays changed from Siemens to Roche. Calibration formulas were developed using 122 KORA FF4
samples, which were measured with both instruments/assays during the time of the method change.
The Siemens measurement results were calibrated to correspond to the Roche measurements.
2.6. Statistical Analysis
The final sample size comprised n = 283 participants. Sociodemographics and other covariates,
nutrition variables and MRI adipose tissue outcomes are presented as arithmetic mean and standard
deviation or as median with first and third quartile for hepatic fat content. Differences between men
and women were determined by t-test, Wilcoxon Rank Sum Test and χ2-Test, as appropriate.
Daily carbohydrate, fat and protein intake was transformed as % of total energy intake by assuming
a mean energy value of 9 kcal/g for fat and fat subgroups, 4 kcal/g for carbohydrates and protein
and 7 kcal/g for alcohol. Correlations between dietary intake and MRI adipose tissue outcomes were
determined by Pearson correlation coefficients and corresponding p-values.
To assess the association of the MRI derived adipose tissue parameters as outcomes with an
isocaloric replacement of carbohydrates by fat or fat subtypes as exposure, a substitution model based
on linear regression was calculated. The substitution model contains total energy intake and all
energy-providing nutrients except carbohydrates (i.e., fat, protein and alcohol) and was additionally
adjusted for potential confounding covariates. Variables for fat, protein and alcohol were adequately
scaled so that β-coefficients for energy-providing nutrients denote a change per 5% of total energy
intake (5E%). Thus, the estimated coefficient for fat can be interpreted as the association of the adipose
tissue parameter with a 5E% increase in fat at the expense of carbohydrates while energy supply
from protein and alcohol remains unchanged. As potentially confounding variables, age, sex and
glycemic status were included in the model. Hepatic fat content was log-transformed before analysis
and therefore estimates have to be interpreted as percent change. We repeated the analyses including
only persons with normal glucose tolerance (n = 183; sensitivity analysis).
R version 3.4.4 was used for all calculations. p-values < 0.05 are considered to denote
statistical significance.
3. Results
The characteristics of the participating men and women as well as for the total sample are
presented in Table 1. The mean age of the entire study cohort was 56.1 (±9.0) years. In comparison
to women, men reported more years of schooling; males had a higher waist circumference, higher
Nutrients 2019, 11, 1151 5 of 13
waist-to-hip-ratio, higher systolic and diastolic blood pressure values, higher LDL-cholesterol and
triglycerides values and lower HDL-cholesterol values. Furthermore, higher values regarding the liver
enzymes GGT, GOT and GPT were seen in male participants in comparison to females. Also, in men
prediabetes and diabetes were more prevalent than in women. They were more often physically active,
less often never-smoker and reported less often no or very low alcohol intake.
Table 1. Baseline characteristics of the whole study sample as well as for men and women (covariables only).
All Men Women
N = 283 N = 161 N = 122 p-value Men vs. Women
Sociodemographics
Age, years 56.1 ± 9.0 56.1 ± 9.4 56.1 ± 8.6 0.976
Education, years of schooling 12.4 ± 2.6 12.9 ± 2.8 11.8 ± 2.4 0.001
Anthropometric measurements
Height, cm 171.7 ± 9.7 177.9 ± 6.7 163.5 ± 6.4 <0.001
Weight, kg 81.4 ± 15.7 88.4 ± 13.1 72.2 ± 14.1 <0.001
BMI, kg/m2 27.6 ± 4.6 27.9 ± 4.1 27.0 ± 5.2 0.107
Waist circumference, cm 97.0 ± 13.7 102.2 ± 11.7 90.2 ± 13.3 <0.001
Hip circumference, cm 106.1 ± 8.3 106.4 ± 6.9 105.7 ± 9.9 0.483
Waist-To-Hip Ratio 0.9 ± 0.1 1.0 ± 0.1 0.9 ± 0.1 <0.001
Blood Pressure
Systolic BP, mmHg 119.9 ± 15.9 125.1 ± 15.4 113.0 ± 13.9 <0.001
Diastolic BP, mmHg 74.8 ± 9.6 76.9 ± 10.0 71.9 ± 8.4 <0.001
Hypertension 94 (33.2%) 64 (39.8%) 30 (24.6%) 0.011
Antihypertensive medication 71 (25.1%) 42 (26.1%) 29 (23.8%) 0.759
Diabetes
Glycemic Status 0.018
normoglycemic 183 (64.7%) 93 (57.8%) 90 (73.8%)
prediabetes 68 (24.0%) 45 (28.0%) 23 (18.9%)
diabetes 32 (11.3%) 23 (14.3%) 9 (7.4%)
Fasting Serum glucose, mg/dL 102.8 ± 18.0 106.6 ± 19.5 97.8 ± 14.3 <0.001
HbA1c, % 5.5 ± 0.6 5.5 ± 0.6 5.5 ± 0.5 0.671
Diabetes medication 20 (7.1%) 13 (8.1%) 7 (5.7%) 0.599
Lipid profile
Total Cholesterol, mg/dL 217.2 ± 36.6 216.1 ± 37.8 218.6 ± 35.0 0.577
HDL Cholesterol, mg/dL 62.8 ± 18.1 56.0 ± 14.9 71.8 ± 17.9 <0.001
LDL Cholesterol, mg/dL 138.8 ± 33.6 141.7 ± 34.1 135.0 ± 32.6 0.099
Triglycerides, mg/dL 127.2 ± 80.4 148.1 ± 95.0 99.5 ± 42.1 <0.001
Lipid lowering medication 31 (11.0%) 16 (9.9%) 15 (12.3%) 0.662
Liver enzymes
GGT - Gammaglutamyltransferase, µkat/L 0.7 ± 0.7 0.8 ± 0.8 0.5 ± 0.5 <0.001
Glutamat-Oxalat-Transaminase (GOT, AST), µkat/L 0.4 ± 0.2 0.4 ± 0.2 0.4 ± 0.2 0.008
Glutamat-Pyruvat-Transaminase (GPT, ALT), µkat/L 0.5 ± 0.3 0.6 ± 0.3 0.4 ± 0.3 <0.001
Behavior
Physical activity
no 69 (24.4%) 49 (30.4%) 20 (16.4%) 0.041
sporadically 41 (14.5%) 22 (13.7%) 19 (15.6%)
regularly around 1 h/week 92 (32.5%) 45 (28.0%) 47 (38.5%)
regularly more than 2 h/week 81 (28.6%) 45 (28.0%) 36 (29.5%)
Smoking 0.249
never-smoker 105 (37.1%) 54 (33.5%) 51 (41.8%)
ex-smoker 122 (43.1%) 76 (47.2%) 46 (37.7%)
smoker 56 (19.8%) 31 (19.3%) 25 (20.5%)
Alcohol consumption *
No/very low 72 (25.4%) 31 (19.3%) 41 (33.6%) <0.001
Moderate 133 (47.0%) 65 (40.4%) 68 (55.7%)
high 78 (27.6%) 65 (40.4%) 13 (10.7%)
Values are arithmetic means and standard deviation for continuous variables and counts and percentages for
categorical variables. p-values from t-test or χ2-Test, where appropriate; * alcohol consumption: no or very low (<2
g/day for women, <5 g/day for men), moderate (≥2 g/day to <10 g/day for women, ≥5 g/day to <20 g/day for men)
and high alcohol intake (≥10 g/day for women, ≥20 g/day for men).
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In Table 2, dietary intake data and the results of the MRI-measurements of adipose tissue for the
total sample and separately for men and women are given. In the total sample, mean energy intake by
carbohydrate and fat intake was 41.8 E% and 37.9 E%, respectively. Men had higher volumes of total
adipose tissue and VAT and higher hepatic fat content compared with women, while women had a
higher volume of subcutaneous adipose tissue than men.
Table 2. Dietary intake as well as MRI variables in the KORA MRI sub study, by sex.
All Men Women
N = 283 N = 161 N = 122 p-value Men vs. Women
Dietary intake data
Carbohydrates, % of total energy intake 41.8 ± 4.0 41.3 ± 4.3 42.5 ± 3.5 0.015
Fat, % of total energy intake 37.9 ± 3.5 37.3 ± 3.5 38.7 ± 3.3 0.001
Ratio fat/carbohydrates 0.9 ± 0.2 0.9 ± 0.2 0.9 ± 0.1 0.895
SFA, % of total energy intake 17.1 ± 1.8 16.8 ± 1.8 17.6 ± 1.8 0.000
MUFA, % of total energy intake 13.4 ± 1.5 13.4 ± 1.5 13.5 ± 1.4 0.562
PUFA, % of total energy intake 4.9 ± 0.8 4.8 ± 0.8 5.0 ± 0.7 0.002
Protein, % of total energy intake 15.3 ± 1.7 14.8 ± 1.5 15.8 ± 1.7 <0.001
Alcohol, % of total energy intake 4.3 ± 3.7 5.9 ± 3.7 2.2 ± 2.3 <0.001
Total energy intake, kcal 2061.5 ± 351.5 1554.8 ± 295.4 <0.001
MRI measurements of adipose tissue
Hepatic fat, PDFF, % (median [1st quartile, 3rd
quartile])
4.5 [2.5,
11.1] 6.6 [3.7, 12.8] 3.0 [1.9, 5.4] <0.001
Total adipose tissue, liter 12.2 ± 5.4 12.8 ± 5.2 11.5 ± 5.5 0.037
Visceral adipose tissue, liter 4.3 ± 2.7 5.5 ± 2.6 2.8 ± 2.1 <0.001
subcutaneous adipose tissue, liter 7.9 ± 3.6 7.3 ± 3.1 8.7 ± 3.9 0.001
Values are arithmetic means and standard deviation, unless otherwise indicated. p-values from t-test or Wilcoxon
Test, where appropriate. SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated
fatty acids.
In Pearson correlation analysis (Figures 2–4), carbohydrate intake showed an inverse correlation
with VAT and hepatic fat content, while total fat intake was significantly positively correlated with
SAT and hepatic fat. Considering the fat subtypes, MUFAs were significantly positively correlated
with all three fat compartments, while PUFAs correlated positively with SAT only and SFAs showed
no significant correlations with VAT, SAT or hepatic fat content.
Replacing total carbohydrates with an isoenergetic amount of total fat was significantly positively
associated with VAT and hepatic fat, while there was no significant association with SAT (Table 3). The
multivariable adjusted β-coefficient for increasing fat intake by 5E% at the expense of carbohydrate
intake was 0.42 L [95% CI: 0.04, 0.79] for VAT. An increase in total fat intake by 5E% at the expense
of carbohydrate was associated with an increase in liver fat by 23%. Substitution of carbohydrates
by SFAs or MUFAs was not significantly associated with VAT and hepatic fat content but with SAT;
substitution by PUFAs was not associated with any of the fat compartments.
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those identified in the main analysis. Furthermore, in the substitution models (Table 3) comparable
results could be generated.
4. Discussion
This study is the first to demonstrate the association between macronutrient intake and different
fat depots measured by MRI, which provided accurate information on the quantity of fat tissue and
liver fat accumulation for each study participant. We could show that isocaloric substitution of total
carbohydrates with an isoenergetic amount of total fat was substantially positively associated with
VAT and hepatic fat, while there was no significant association with SAT. Substitution of carbohydrates
by PUFAs was not significantly associated with any of the fat compartments while a substitution by
SFAs or MUFAs was significantly associated with SAT but not VAT and hepatic fat content.
The findings on isocaloric substitution of carbohydrates by SFAs are in line with controlled
intervention studies, which reported that an increase of dietary SFA in isocaloric substitution
of carbohydrates [19] or PUFA [20] increased hepatic and—contrary to our results—visceral fat
accumulation in healthy subjects. Prior cross-sectional studies found that persons with higher intake
of SFA have increased liver fat content, determined by liver enzymes measurement [21,22]. In general,
the associations with hepatic fat seems to point in the same direction, although our results were not
statistically significant which is probably due to the low number of persons included.
Isocaloric substitution of carbohydrates with total fat was significantly positively associated with
VAT, hepatic fat but not SAT in the present study. To the best of our knowledge, no other studies
investigated this association. However, due to prior work it can be assumed that an increase in the
intake of total fat and SFA may promote visceral fat accumulation [20,23] and non-alcoholic fatty liver
disease [24]. Furthermore, in several prior intervention studies, high-fat diets resulted in increased liver
fat accumulation in both humans and rodents when compared with low-fat diets [19,25,26]. On the
other hand, a prior cross-sectional study found an association between dietary fat and weight in adult
women without diabetes but could not show a relationship with VAT measured by dual-energy X-ray
absorptiometry [27]. The different findings in the studies could be due to methodological differences
in assessing diet and measurement of the fat compartments. For example, in the study by Greenfield
et al. [27] diet was assessed using the Oxford FFQ and VAT was measured using dual-energy X-ray
absorptiometry, while in the present study dietary fat intake was assessed using a blended approach
leading to more precise and valid intake estimates as compared to FFQ-based intake data [28] and VAT
was determined by MRI.
Contrary to the results of the substitution models, we found no significant correlation between
total fat intake and VAT but with SAT. As total fat is the sum of different fat types, it can be assumed
that the consumption of certain fat subtypes might be responsible for the different results. Indeed, our
study showed a strong positive association between the intake of MUFAs and PUFAs (more than 50%
of the total dietary fat) but not SFAs and SAT. This likely explains the positive correlation between total
fat intake and SAT.
Independent of the caloric content, high-fat diets up-regulate inflammatory mediators [29],
promote unfavorable epigenetic profiles [30,31], stimulate hepatic bile acid synthesis and subsequently
may promote tumorigenesis [32,33]. There is also evidence that the type of fat consumed plays an
important role in this context; isocaloric diets with a reduced SFA or increased MUFA or PUFA content,
appear to reduce liver fat [34]. Main food sources of SFAs are foods of animal origin high in fat such as
cream, cheese, butter, other whole milk dairy products and fatty meats; however, also some vegetables
fats are rich in SFA, for example, coconut and palm kernel oils. A prior German study investigating
whether and to what extent patterns of nutrient intake are associated with VAT and subcutaneous
abdominal adipose tissue (SAAT) determined by MRI observed that VAT was primarily explained by
nutrient quality, while SAAT was explained by total energy intake [9]. In that study nutrients found in
animal (except for dairy) products were associated with VAT [9]; but unfortunately, the association
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between macronutrient composition and different fat depots using substitution modelling was not
investigated and thus, the results are not comparable to our findings [9].
Carbohydrate consumption correlated negatively with VAT and hepatic fat content in our study.
This finding is contrary to the results of studies reporting that diets higher in refined carbohydrates
possibly are accompanied by an increase of liver fat [35]. The different findings are probably due
to differences in the quality of consumed carbohydrates. Ideally, the food supplied should contain
low-glycemic carbohydrates such as minimally processed grains, legumes and non-starchy fruits and
vegetables [36]. The benefit through the consumption of carbohydrates with a low-glycemic index was
underpinned by a recent RCT [37].
Differences between VAT and SAT
There are many differences between VAT and SAT. Compared to SAT, VAT adipocytes have a
higher rate of lipolysis, which is more readily stimulated by catecholamines and less readily stimulated
by insulin [38]. VAT is metabolically active and produces more than 20 different hormones, such
as the stress hormone cortisol, leptin and adiponectin (responsible for regulating satiety and food
intake) [39]. Subsequently, insulin resistance and many of its related features could arise from
VAT [40,41]. Furthermore, in contrast to the SAT, the VAT is anatomically linked to the liver via portal
vein. Thus, VAT can deliver free fatty acids and adipokines/cytokines directly to the liver, which may
explain the relationship between VAT and an increased content of liver fat [42]. Preadipocytes from
SAT depots have a greater capacity than VAT to differentiate into numerous, small, insulin-sensitive,
adipocytes, which act as lipid-storing cells [43]. SAT can be considered as the normal physiological
buffer for excess energy intake in form of a hypercaloric diet in combination with limited energy
expenditure via physical activity. Adipocytes in SAT store excess free fatty acids and glycerol in form
of triglycerides [44] and when the capacity to store excess energy and the ability to generate new
adipocytes is impaired, fat is stored outside the SAT [45]. Altogether, the anatomical distribution
of adipose tissue shows a subject-to-subject variation, dependent on age, sex, ethnicity, nutritional
intake and the autonomic regulation of energy homeostasis [46,47] but the mechanisms involved in
determination of fatness and fat distribution are barely understood so far. Future research should focus
on the molecular and cellular mechanisms in different adipose tissue depots and on adipocyte-specific
factors to better understand how the growth and turnover of visceral versus subcutaneous adipocytes
is regulated.
The limitations of the study are the relatively low number of participants and the enrichment of
the study sample with persons with prediabetes and diabetes. However, when conducting sensitivity
analyses including normoglycemic men and women only, the results pointed in the same direction as
those found in the main analyses. Furthermore, our results are not generalizable to other populations
and ethnicities or other age-groups because only Caucasians with a mean age of 56.1 years were
included. In addition, the cross-sectional design of the present study did not allow to postulate a causal
link between macronutrient intake and fat enrichment in different body compartments. The major
strengths of our study are the well-characterized participants and the availability of data on lifestyle
and multiple risk factors, measured following standardized protocols. A further important strength is
the accurate measurement of adipose tissue compartments using an MRI for the quantification of fat.
In conclusion, using MRI and a relatively accurate dietary assessment method compared to other
methods [48], we observed an association between fat accumulation at specific anatomic locations
and macronutrient composition among adult German men and women. Specifically, the isocaloric
substitution of carbohydrates with fat was associated with higher hepatic fat content and visceral fat
accumulation. These findings provide the basis for future studies that investigate the effect of diet and
on metabolic and molecular consequences of regional obesity. Also, the results can contribute to the
long-lasting discussion on the diet’s optimal fat content.
Nutrients 2019, 11, 1151 11 of 13
Author Contributions: Conceptualization, C.M.; Methodology, C.M. and J.L.; Formal Analysis, S.R.; Investigation,
F.B., C.L.S., E.W., A.P., J.L.; Resources and Data Curation, A.P., B.T., C.M., R.L., J.L., F.B.; Writing—Original Draft
Preparation, C.M.; Writing—Review & Editing, C.M., S.R., E.W., R.L., B.T., F.B., A.P., C.L.S. and J.L.
Funding: This research was funded by the German Research Foundation (DFG, Bonn, Germany) grant-number
245222810).
Acknowledgments: The KORA study was initiated and financed by the Helmholtz Zentrum München—German
Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and
Research (BMBF) and by the State of Bavaria. The KORA-MRI sub-study was supported by an unrestricted
research grant from Siemens Healthcare.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Obesity and Overweight. 2017. Available online: http://www.who.int/news-room/fact-sheets/detail/obesity-
and-overweight (accessed on 17 June 2018).
2. Haffner, S.M. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
Obesity (Silver Spring) 2006, 14, 121–127. [CrossRef]
3. Lim, S.; Meigs, J.B. Links between ectopic fat and vascular disease in humans. Arterioscler. Thromb. Vasc. Biol.
2014, 34, 1820–1826. [CrossRef] [PubMed]
4. Storz, C.; Heber, S.D.; Rospleszcz, S.; Machann, J.; Sellner, S.; Nikolaou, K.; Lorbeer, R.; Gatidis, S.; Elser, S.;
Peters, A.; et al. The role of visceral and subcutaneous adipose tissue measurements and their ratio by
magnetic resonance imaging in subjects with prediabetes, diabetes and healthy controls from a general
population without cardiovascular disease. Br. J. Radiol. 2018, 91, 20170808. [CrossRef]
5. Austin, G.L.; Ogden, L.G.; Hill, J.O. Trends in carbohydrate, fat and protein intakes and association with
energy intake in normal.-weight, overweight and obese individuals: 1971–2006. Am. J. Clin. Nutr. 2011, 93,
836–843. [CrossRef] [PubMed]
6. Ludwig, D.S.; Willett, W.C.; Volek, J.S.; Neuhouser, M.L. Dietary fat: From foe to friend? Science 2018, 362,
764–770. [CrossRef] [PubMed]
7. Cohen, E.; Cragg, M.; deFonseka, J.; Hite, A.; Rosenberg, M.; Zhou, B. Statistical review of US macronutrient
consumption data, 1965–2011: Americans have been following dietary guidelines, coincident with the rise in
obesity. Nutrition 2015, 31, 727–732. [CrossRef]
8. Boqué, N.; Campion, J.; Paternain, L.; Garcia-Diaz, D.F.; Galarraga, M.; Portillo, M.P.; Milagro, F.I.; Ortiz de
Solorzano, C.; Martinez, J.A. Influence of dietary macronutrient composition on adiposity and cellularity of
different fat depots in Wistar rats. J. Physiol. Biochem. 2009, 65, 387–395. [CrossRef]
9. Fischer, K.; Moewes, D.; Koch, M.; Müller, H.P.; Jacobs, G.; Kassubek, J.; Lieb, W.; Nöthlings, U.
MRI-determined total volumes of visceral and subcutaneous abdominal and trunk adipose tissue are
differentially and sex-dependently associated with patterns of estimated usual nutrient intake in a northern
German population. Am. J. Clin. Nutr. 2015, 101, 794–807. [CrossRef] [PubMed]
10. Laxy, M.; Knoll, G.; Schunk, M.; Meisinger, C.; Huth, C.; Holle, R. Quality of diabetes care in Germany
improved from 2000 to 2007 to 2014 but improvements diminished since 2007. Evidence from the
population-based KORA studies. PLoS ONE 2016, 11, e0164704. [CrossRef]
11. Bamberg, F.; Hetterich, H.; Rospleszcz, S.; Lorbeer, R.; Auweter, S.D.; Schlett, C.L.; Schafnitzel, A.; Bayerl, C.;
Schindler, A.; Saam, T.; et al. Subclinical disease burden as assessed by whole-body MRI in subjects with
prediabetes, subjects with diabetes and normal control subjects from the general population: The KORA-MRI
study. Diabetes 2017, 66, 158–169. [CrossRef]
12. Freese, J.; Feller, S.; Harttig, U.; Kleiser, C.; Linseisen, J.; Fischer, B.; Leitzmann, M.F.; Six-Merker, J.;
Michels, K.B.; Nimptsch, K.; et al. Development and evaluation of a short 24-h food list as part of a blended
dietary assessment strategy in large-scale cohort studies. Eur. J. Clin. Nutr. 2014, 68, 324–329. [CrossRef]
13. Tooze, J.A.; Kipnis, V.; Buckman, D.W.; Carroll, R.J.; Freedman, L.S.; Guenther, P.M.; Krebs-Smith, S.M.;
Subar, A.F.; Dodd, K.W. A mixed-effects model approach for estimating the distribution of usual intake of
nutrients: The NCI method. Stat. Med. 2010, 29, 2857–2868. [CrossRef] [PubMed]
14. Haubrock, J.; Nöthlings, U.; Volatier, J.L.; Dekkers, A.; Ocké, M.; Harttig, U.; Illner, A.K.; Knüppel, S.;
Andersen, L.F.; Boeing, H.; et al. Estimating usual food intake distributions by using the multiple source
method in the EPIC-Potsdam Calibration Study. J. Nutr. 2011, 141, 914–920. [CrossRef] [PubMed]
Nutrients 2019, 11, 1151 12 of 13
15. Hetterich, H.; Bayerl, C.; Peters, A.; Heier, M.; Linkohr, B.; Meisinger, C.; Auweter, S.; Kannengießer, S.A.;
Kramer, H.; Ertl-Wagner, B.; et al. Feasibility of a three-step magnetic resonance imaging approach for the
assessment of hepatic steatosis in an asymptomatic study population. Eur. Radiol. 2016, 26, 1895–1904.
[CrossRef] [PubMed]
16. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications.
Part 1: Diagnosis and Classification of Diabetes Mellitus; Report of a WHO Consultation; WHO: Geneva,
Switzerland, 1999.
17. Meisinger, C.; Thorand, B.; Schneider, A.; Stieber, J.; Döring, A.; Löwel, H. Sex differences in risk factors for
incident type 2 diabetes mellitus: The MONICA Augsburg cohort study. JAMA Intern. Med. 2002, 162, 82–89.
[CrossRef]
18. Meisinger, C.; Löwel, H.; Thorand, B.; Döring, A. Leisure time physical activity and the risk of type 2 diabetes
in men and women from the general population. The MONICA/KORA Augsburg Cohort Study. Diabetologia
2005, 48, 27–34. [CrossRef] [PubMed]
19. Westerbacka, J.; Lammi, K.; Häkkinen, A.M.; Rissanen, A.; Salminen, I.; Aro, A.; Yki-Järvinen, H. Dietary fat
content modifies liver fat in overweight nondiabetic subjects. J. Clin. Endocrinol. Metab. 2005, 90, 2804–2809.
[CrossRef]
20. Rosqvist, F.; Iggman, D.; Kullberg, J.; Cedernaes, J.; Johansson, H.E.; Larsson, A.; Johansson, L.; Ahlström, H.;
Arner, P.; Dahlman, I.; et al. Overfeeding polyunsaturated and saturated fat causes distinct effects on liver
and visceral fat accumulation in humans. Diabetes 2014, 63, 2356–2368. [CrossRef]
21. Petersson, H.; Arnlöv, J.; Zethelius, B.; Riserus, U. Serum fatty acid composition and insulin resistance are
independently associated with liver fat markers in elderly men. Diabetes Res. Clin. Pract. 2010, 87, 379–384.
[CrossRef]
22. Allard, J.P.; Aghdassi, E.; Mohammed, S.; Raman, M.; Avand, G.; Arendt, B.M.; Jalali, P.; Kandasamy, T.;
Prayitno, N.; Sherman, M.; et al. Nutritional assessment and hepatic fatty acid composition in non-alcoholic
fatty liver disease (NAFLD): A cross-sectional study. J. Hepatol. 2008, 48, 300–307. [CrossRef]
23. Bray, G.A.; Krauss, R.M. Overfeeding of polyunsaturated versus saturated fatty acids reduces ectopic fat.
Diabetes 2014, 63, 2222–2224. [CrossRef]
24. Leamy, A.K.; Egnatchik, R.A.; Young, J.D. Molecular mechanisms and the role of saturated fatty acids in the
progression of non-alcoholic fatty liver disease. Prog. Lipid Res. 2013, 52, 165–174. [CrossRef]
25. Van Herpen, N.A.; Schrauwen-Hinderling, V.B.; Schaart, G.; Mensink, R.P.; Schrauwen, P. Three weeks
on a high-fat diet increases intrahepatic lipid accumulation and decreases metabolic flexibility in healthy
overweight men. J. Clin. Endocrinol. Metab. 2011, 96, E691–E695. [CrossRef]
26. De Meijer, V.E.; Le, H.D.; Meisel, J.A.; Akhavan Sharif, M.R.; Pan, A.; Nose, V.; Puder, M. Dietary fat intake
promotes the development of hepatic steatosis independently from excess caloric consumption in a murine
model. Metabolism 2010, 59, 1092–1105. [CrossRef]
27. Greenfield, J.R.; Samaras, K.; Jenkins, A.B.; Kelly, P.J.; Spector, T.D.; Campbell, L.V. Moderate alcohol
consumption, dietary fat composition and abdominal obesity in women: Evidence for gene-environment
interaction. J. Clin. Endocrinol. Metab. 2003, 88, 5381–5386. [CrossRef] [PubMed]
28. Carroll, R.J.; Midthune, D.; Subar, A.F.; Shumakovich, M.; Freedman, L.S.; Thompson, F.E.; Kipnis, V. Taking
advantage of the strengths of 2 different dietary assessment instruments to improve intake estimates for
nutritional epidemiology. Am. J. Epidemiol. 2012, 175, 340–347. [CrossRef]
29. Valdearcos, M.; Xu, A.W.; Koliwad, S.K. Hypothalamic inflammation in the control of metabolic function.
Annu. Rev. Physiol. 2015, 77, 131–160. [CrossRef] [PubMed]
30. Perfilyev, A.; Dahlman, I.; Gillberg, L.; Rosqvist, F.; Iggman, D.; Volkov, P.; Nilsson, E.; Risérus, U.; Ling, C.
Impact of polyunsaturated and saturated fat overfeeding on the DNA-methylation pattern in human adipose
tissue: A randomized controlled trial. Am. J. Clin. Nutr. 2017, 105, 991–1000. [CrossRef]
31. Martinez, J.A.; Milagro, F.I.; Claycombe, K.J.; Schalinske, K.L. Epigenetics in adipose tissue, obesity, weight
loss and diabetes. Adv. Nutr. 2014, 5, 71–81. [CrossRef]
32. Ocvirk, S.; O’Keefe, S.J. Influence of bile acids on colorectal cancer risk: Potential mechanisms mediated by
diet—Gut microbiota interactions. Curr. Nutr. Rep. 2017, 6, 315–322. [CrossRef]
33. Ou, J.; Carbonero, F.; Zoetendal, E.G.; DeLany, J.P.; Wang, M.; Newton, K.; Gaskins, H.R.; O’Keefe, S.J. Diet,
microbiota and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am. J.
Clin. Nutr. 2013, 98, 11–20. [CrossRef] [PubMed]
Nutrients 2019, 11, 1151 13 of 13
34. Ryan, M.C.; Itsiopoulos, C.; Thodis, T.; Ward, G.; Trost, N.; Hofferberth, S.; O’Dea, K.; Desmond, P.V.;
Johnson, N.A.; Wilson, A.M. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in
individuals with non-alcoholic fatty liver disease. J. Hepatol. 2013, 59, 138–143. [CrossRef]
35. Schwarz, J.M.; Noworolski, S.M.; Wen, M.J.; Dyachenko, A.; Prior, J.L.; Weinberg, M.E.; Herraiz, L.A.;
Tai, V.W.; Bergeron, N.; Bersot, T.P.; et al. Effect of a high-fructose weight-maintaining diet on lipogenesis
and liver fat. J. Clin. Endocrinol. Metab. 2015, 100, 2434–2442. [CrossRef]
36. Augustin, L.S.A.; Kendall, C.W.C.; Jenkins, D.J.A.; Willett, W.C.; Astrup, A.; Barclay, A.W.; Björck, I.;
Brand-Miller, J.C.; Brighenti, F.; Buyken, A.E.; et al. Glycemic index, glycemic load and glycemic response:
An international scientific consensus summit from the International Carbohydrate Quality Consortium
(ICQC). Nutr. Metab. Cardiovasc. 2015, 25, 795–815. [CrossRef] [PubMed]
37. Bawden, S.; Stephenson, M.; Falcone, Y.; Lingava, M.; Ciampi, E.; Hunter, K.; Bligh, F.; Schirra, J.; Taylor, M.;
Morris, P.; et al. Increased liver fat and glycogen stores after consumption of high versus low glycaemic
index food: A randomized crossover study. Diabetes Obes. Metab. 2017, 19, 70–77. [CrossRef]
38. Zierath, J.R.; Livingston, J.N.; Thorne, A.; Bolinder, J.; Reynisdottir, S.; Lonnqvist, F.; Arner, P. Regional
difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: Relation to insulin
receptor phosphorylation and intracellular signalling through the insulin receptor substrate-I pathway.
Diabetologia 1998, 41, 1343–1354. [CrossRef]
39. Wagenknecht, L.E.; Langefeld, C.D.; Scherzinger, A.L.; Norris, J.M.; Haffner, S.M.; Saad, M.F.; Bergman, R.N.
Insulin sensitivity, insulin secretion and abdominal fat: The Insulin Resistance Atherosclerosis Study (IRAS)
Family Study. Diabetes 2003, 52, 2490–2496. [CrossRef]
40. Bjorntorp, P. “Portal” adipose tissue as a generator of risk factors for cardiovascular disease and diabetes.
Arteriosclerosis 1990, 10, 493–496. [CrossRef]
41. Despres, J.P.; Lemieux, I. Abdominal obesity and metabolic syndrome. Nature 2006, 444, 881–887. [CrossRef]
42. Van der Poorten, D.; Milner, K.L.; Hui, J.; Hodge, A.; Trenell, M.I.; Kench, J.G.; London, R.; Peduto, T.;
Chisholm, D.J.; George, J. Visceral fat: A key mediator of steatohepatitis in metabolic liver disease. Hepatology
2008, 48, 449–457. [CrossRef]
43. Hauner, H.; Wabitsch, M.; Pfeiffer, E.F. Differentiation of adipocyte precursor cells from obese and nonobese
adult women and from different adipose tissue sites. Horm. Metab. Res. Suppl. 1988, 19, 35–39. [PubMed]
44. Freedland, E.S. Role of critical visceral adipose tissue threshold in metabolic syndrome: Implications for
controlling dietary carbohydrates: A review. Nutr. Metab. 2004, 1, 12. [CrossRef] [PubMed]
45. Frayn, K.N. Adipose tissue as a buffer for daily lipid flux. Diabetologia 2002, 45, 1201–1210. [CrossRef]
46. Nazare, J.A.; Smith, J.D.; Borel, A.L.; Haffner, S.M.; Balkau, B.; Ross, R.; Massien, C.; Almeras, N.; Despres, J.P.
Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat and
cardiometabolic risk profile: The international study of prediction of intra-abdominal adiposity and its
relationship with cardiometabolic risk/intra-abdominal adiposity. Am. J. Clin. Nutr. 2012, 96, 714–726.
47. Lee, M.J.; Wu, Y.; Fried, S.K. Adipose tissue heterogeneity: Implication of depot differences in adipose tissue
for obesity complications. Mol. Asp. Med. 2013, 34, 1–11. [CrossRef] [PubMed]
48. Conrad, J.; Nöthlings, U. Innovative approaches to estimate individual usual dietary intake in large-scale
epidemiological studies. Proc. Nutr. Soc. 2017, 76, 213–219. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
